<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34119855</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3360</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Psychoneuroendocrinology</Title><ISOAbbreviation>Psychoneuroendocrinology</ISOAbbreviation></Journal><ArticleTitle>Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19.</ArticleTitle><Pagination><StartPage>105295</StartPage><MedlinePgn>105295</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psyneuen.2021.105295</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0306-4530(21)00169-4</ELocationID><Abstract><AbstractText>The majority of COVID-19 survivors experience long-term neuropsychiatric symptoms such as fatigue, sleeping difficulties, depression and anxiety. We propose that neuroimmune cross-talk via inflammatory cytokines such as interleukin-6 (IL-6) could underpin these long-term COVID-19 symptoms. This hypothesis is supported by several lines of research, including population-based cohort and genetic Mendelian Randomisation studies suggesting that inflammation is associated with fatigue and sleeping difficulties, and that IL-6 could represent a possible causal driver for these symptoms. Immune activation following COVID-19 can disrupt T helper 17 (T<sub>H</sub>17) and regulatory T (T<sub>reg</sub>) cell responses, affect central learning and emotional processes, and lead to a vicious cycle of inflammation and mitochondrial dysfunction that amplifies the inflammatory process and results in immuno-metabolic constraints on neuronal energy metabolism, with fatigue being the ultimate result. Increased cytokine activity drives this process and could be targeted to interrupt it. Therefore, whether persistent IL-6 dysregulation contributes to COVID-19-related long-term fatigue, sleeping difficulties, depression, and anxiety, and whether targeting IL-6 pathways could be helpful for treatment and prevention of long COVID are important questions that require investigation. This line of research could inform new approaches for treatment and prevention of long-term neuropsychiatric symptoms of COVID-19. Effective treatment and prevention of this condition could also help to stem the anticipated rise in depression and other mental illnesses ensuing this pandemic.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kappelmann</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Research in Translational Psychiatry, Max-Planck-Institute of Psychiatry, Munich, Germany; International Max Planck Research School for Translational Psychiatry (IMPRS-TP), Munich, Germany. Electronic address: n.kappelmann@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dantzer</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Symptom Research, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khandaker</LastName><ForeName>Golam M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Department of Psychiatry, University of Cambridge, Cambridge, UK; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA016672</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>201486/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS073939</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MC_PC_17213</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S037675/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychoneuroendocrinology</MedlineTA><NlmUniqueID>7612148</NlmUniqueID><ISSNLinking>0306-4530</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Psychoneuroendocrinology. 2021 Sep;131:105359. doi: 10.1016/j.psyneuen.2021.105359</RefSource><PMID Version="1">34303538</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015213" MajorTopicYN="N">Neuroimmunomodulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="N">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Interleukin-6</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Sleep</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>13</Day><Hour>20</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34119855</ArticleId><ArticleId IdType="pmc">PMC8172271</ArticleId><ArticleId IdType="doi">10.1016/j.psyneuen.2021.105295</ArticleId><ArticleId IdType="pii">S0306-4530(21)00169-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Badini I., Coleman J.R., Hagenaars S.P., Hotopf M., Breen G., Lewis C.M., Fabbri C. Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption. Psychol. Med. 2020:1&#x2013;11. doi: 10.1017/S0033291720002342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291720002342</ArticleId><ArticleId IdType="pmc">PMC8961332</ArticleId><ArticleId IdType="pubmed">32624019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235&#x2013;238. doi: 10.1038/nature04753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04753</ArticleId><ArticleId IdType="pubmed">16648838</ArticleId></ArticleIdList></Reference><Reference><Citation>Bovijn J., Lindgren C.M., Holmes M.V. Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19. Lancet Rheumatol. 2020;2:e658&#x2013;e659. doi: 10.1016/S2665-9913(20)30345-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30345-3</ArticleId><ArticleId IdType="pmc">PMC7518829</ArticleId><ArticleId IdType="pubmed">33015641</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuron L., Gumnick J.F., Musselman D.L., Lawson D.H., Reemsnyder A., Nemeroff C.B., Miller A.H. Neurobehavioral effects of interferon-&#x3b1; in cancer patients phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643&#x2013;652. doi: 10.1016/S0893-133X(01)00407-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0893-133X(01)00407-9</ArticleId><ArticleId IdType="pubmed">11927189</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;369:9&#x2013;10. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M., Aaron J.G., Claassen J., Rabbani L.E., Hastie J., Hochman B.R., Salazar-Schicchi J., Yip N.H., Brodie D., O&#x2019;Donnell M.R. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763&#x2013;1770. doi: 10.1016/S0140-6736(20)31189-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31189-2</ArticleId><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R., Heijnen C.J., Kavelaars A., Laye S., Capuron L. The neuroimmune basis of fatigue. Trends Neurosci. 2014;37:39&#x2013;46. doi: 10.1016/j.tins.2013.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2013.10.003</ArticleId><ArticleId IdType="pmc">PMC3889707</ArticleId><ArticleId IdType="pubmed">24239063</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R., O&#x2019;Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46&#x2013;56. doi: 10.1038/nrn2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2297</ArticleId><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. 2020 doi: 10.1101/2020.12.24.20248802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S., Meschiari M., Gibellini L., Bellinazzi C., Borella R., Fidanza L., Gozzi L., Iannone A., Lo Tartaro D., Mattioli M., Paolini A., Menozzi M., Mili&#x107; J., Franceschi G., Fantini R., Tonelli R., Sita M., Sarti M., Trenti T., Brugioni L., Cicchetti L., Facchinetti F., Pietrangelo A., Clini E., Girardis M., Guaraldi G., Mussini C., Cossarizza A. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat. Commun. 2020;11:3434. doi: 10.1038/s41467-020-17292-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17292-4</ArticleId><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.-H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., Marron T.U., Xie H., Patel M., Tuballes K., Van Oekelen O., Rahman A., Kovatch P., Aberg J.A., Schadt E., Jagannath S., Mazumdar M., Charney A.W., Firpo-Betancourt A., Mendu D.R., Jhang J., Reich D., Sigel K., Cordon-Cardo C., Feldmann M., Parekh S., Merad M., Gnjatic S. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636&#x2013;1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., Attree E., Heightman M. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-&#xad;based study. BMJ Open. 2021;11 doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitrov S., Lange T., Benedict C., Nowell M.A., Jones S.A., Scheller J., Rose&#x2010;John S., Born J., Dimitrov S., Lange T., Benedict C., Nowell M.A., Jones S.A., Scheller J., Rose&#x2010;John S., Born J. Sleep enhances IL&#x2010;6 trans&#x2010;signaling in humans. FASEB J. 2006;20:2174&#x2013;2176. doi: 10.1096/fj.06-5754fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.06-5754fje</ArticleId><ArticleId IdType="pubmed">16912152</ArticleId></ArticleIdList></Reference><Reference><Citation>Du P., Geng J., Wang F., Chen X., Huang Z., Wang Y. Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome. Int. J. Med. Sci. 2021;18:1356&#x2013;1362. doi: 10.7150/ijms.53564.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.53564</ArticleId><ArticleId IdType="pmc">PMC7893562</ArticleId><ArticleId IdType="pubmed">33628091</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried E.I., von Stockert S., Haslbeck J.M.B., Lamers F., Schoevers R.A., Penninx B.W.J.H. Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates. Psychol. Med. 2019:1&#x2013;9. doi: 10.1017/S0033291719002770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291719002770</ArticleId><ArticleId IdType="pubmed">31615595</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakis M.K., Malik R., Gill D., Franceschini N., Sudlow C.L.M., Dichgans M. Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a mendelian randomization study. Circ. Genom. Precis. Med. 2020;13 doi: 10.1161/CIRCGEN.119.002872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGEN.119.002872</ArticleId><ArticleId IdType="pmc">PMC7299212</ArticleId><ArticleId IdType="pubmed">32397738</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakis M.K., Malik R., Li X., Gill D., Levin M.G., Vy H.M.T., Judy R., Ritchie M., Verma S.S., Nadkarni G.N., Damrauer S.M., Theodoratou E., Dichgans M. Genetically downregulated interleukin-6 signaling is associated with a favorable cardiometabolic profile. Circulation. 2021;143:1177&#x2013;1180. doi: 10.1161/CIRCULATIONAHA.120.052604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052604</ArticleId><ArticleId IdType="pubmed">33720771</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazavi A., Ganji A., Keshavarzian N., Rabiemajd S., Mosayebi G. Cytokine profile and disease severity in patients with COVID-19. Cytokine. 2021;137 doi: 10.1016/j.cyto.2020.155323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155323</ArticleId><ArticleId IdType="pmc">PMC7524708</ArticleId><ArticleId IdType="pubmed">33045526</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon A.C., Mouncey P.R., Al-beidh F., Kathryn M., Nichol A.D., Arabi Y.M., Annane D. Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N. Engl. J. Med. 2021;384:1491&#x2013;1502. doi: 10.1056/NEJMoa2100433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2100433</ArticleId><ArticleId IdType="pmc">PMC7953461</ArticleId><ArticleId IdType="pubmed">33631065</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosse L., Hoogenboezem T., Ambr&#xe9;e O., Bellingrath S., J&#xf6;rgens S., de Wit H.J., Wijkhuijs A.M., Arolt V., Drexhage H.A. Deficiencies of the T and natural killer cell system in major depressive disorder. Brain Behav. Immun. 2016;54:38&#x2013;44. doi: 10.1016/j.bbi.2015.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.12.003</ArticleId><ArticleId IdType="pubmed">26674997</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Critchley H.D. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry. 2009;66:407&#x2013;414. doi: 10.1016/j.biopsych.2009.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2009.03.015</ArticleId><ArticleId IdType="pmc">PMC2885494</ArticleId><ArticleId IdType="pubmed">19423079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988;12:123&#x2013;137. doi: 10.1016/S0149-7634(88)80004-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0149-7634(88)80004-6</ArticleId><ArticleId IdType="pubmed">3050629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewlett S., Chalder T., Choy E., Cramp F., Davis B., Dures E., Nicholls C., Kirwan J. Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology. 2011;50:1004&#x2013;1006. doi: 10.1093/rheumatology/keq282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keq282</ArticleId><ArticleId IdType="pubmed">20819797</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E.A., O&#x2019;Connor R.C., Perry V.H., Tracey I., Wessely S., Arseneault L., Ballard C., Christensen H., Cohen Silver R., Everall I., Ford T., John A., Kabir T., King K., Madan I., Michie S., Przybylski A.K., Shafran R., Sweeney A., Worthman C.M., Yardley L., Cowan K., Cope C., Hotopf M., Bullmore E. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547&#x2013;560. doi: 10.1016/S2215-0366(20)30168-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30168-1</ArticleId><ArticleId IdType="pmc">PMC7159850</ArticleId><ArticleId IdType="pubmed">32304649</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang, Yeming, Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., Luo J., Huang Z., Tu S., Zhao Y., Chen L., Li Xu, D., Yanping, Li C., Li Peng, L., Yong, Xie W., Cui D., Shang L., Fan G., Xu J., Wang G., Wang Ying, Zhong J., Wang C., Wang J., Zhang D., Cao B. Vol. 397. 2021. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study; pp. 220&#x2013;232. (Lancet).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter C.A., Jones S.A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 2015;16:448&#x2013;457. doi: 10.1038/ni.3153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3153</ArticleId><ArticleId IdType="pubmed">25898198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyrich K.L., Machado P.M. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat. Rev. Rheumatol. 2021;17:71&#x2013;72. doi: 10.1038/s41584-020-00562-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00562-2</ArticleId><ArticleId IdType="pmc">PMC7747184</ArticleId><ArticleId IdType="pubmed">33339986</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokela M., Virtanen M., Batty G., Kivim&#xe4;ki M. Inflammation and specific symptoms of depression. JAMA Psychiatry. 2016;73:87&#x2013;88. doi: 10.1001/jamapsychiatry.2015.1977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2015.1977</ArticleId><ArticleId IdType="pubmed">26579988</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandaker G.M., Pearson R.M., Zammit S., Lewis G., Jones P.B. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71:1121&#x2013;1128. doi: 10.1001/jamapsychiatry.2014.1332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2014.1332</ArticleId><ArticleId IdType="pmc">PMC4561502</ArticleId><ArticleId IdType="pubmed">25133871</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler C.A., Freitas T.H., Maes M., de Andrade N.Q., Liu C.S., Fernandes B.S., Stubbs B., Solmi M., Veronese N., Herrmann N., Raison C.L., Miller B.J., Lanct&#xf4;t K.L., Carvalho A.F. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr. Scand. 2017;135:373&#x2013;387. doi: 10.1111/acps.12698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acps.12698</ArticleId><ArticleId IdType="pubmed">28122130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacourt T.E., Vichaya E.G., Chiu G.S., Dantzer R., Heijnen C.J. The high costs of low-grade inflammation: persistent fatigue as a consequence of reduced cellular-energy availability and non-adaptive energy expenditure. Front. Behav. Neurosci. 2018;12:1&#x2013;20. doi: 10.3389/fnbeh.2018.00078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2018.00078</ArticleId><ArticleId IdType="pmc">PMC5932180</ArticleId><ArticleId IdType="pubmed">29755330</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing A.G., Lorenc A., del Molino del Barrio I., Das A., Fish M., Monin L., Mu&#xf1;oz-Ruiz M., McKenzie D.R., Hayday T.S., Francos-Quijorna I., Kamdar S., Joseph M., Davies D., Davis R., Jennings A., Zlatareva I., Vantourout P., Wu Y., Sofra V., Cano F., Greco M., Theodoridis E., Freedman J.D., Gee S., Chan J.N.E., Ryan S., Bugallo-Blanco E., Peterson P., Kisand K., Haljasm&#xe4;gi L., Chadli L., Moingeon P., Martinez L., Merrick B., Bisnauthsing K., Brooks K., Ibrahim M.A.A., Mason J., Lopez Gomez F., Babalola K., Abdul-Jawad S., Cason J., Mant C., Seow J., Graham C., Doores K.J., Di Rosa F., Edgeworth J., Shankar-Hari M., Hayday A.C. Vol. 26. 2020. A dynamic COVID-19 immune signature includes associations with poor prognosis; pp. 1623&#x2013;1635. (Nat. Med.).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers F., Milaneschi Y., Vinkers C.H., Schoevers R.A., Giltay E.J., Penninx B.W.J.H. Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study. Brain Behav. Immun. 2020;88:174&#x2013;183. doi: 10.1016/j.bbi.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.002</ArticleId><ArticleId IdType="pubmed">32272220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor D.A., Harbord R.M., Sterne J.A.C., Timpson N., Davey Smith G. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat. Med. 2008;27:1133&#x2013;1163. doi: 10.1002/sim.3034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3034</ArticleId><ArticleId IdType="pubmed">17886233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner A.M., Robinson D.A., Yang L., Williams C.F., Newman L.M., Breen J.J., Eisinger R.W., Schneider J.S., Adimora A.A., Erbelding E.J. Toward understanding COVID-19 recovery: National Institutes of Health workshop on postacute COVID-19. Ann. Intern. Med. 2021:M21&#x2013;1043. doi: 10.7326/M21-1043.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-1043</ArticleId><ArticleId IdType="pmc">PMC8025940</ArticleId><ArticleId IdType="pubmed">33780290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021:1&#x2013;22. doi: 10.1101/2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D., Giles J.R., Baxter A.E., Oldridge D.A., Greenplate A.R., Wu J.E., Alanio C., Kuri-Cervantes L., Pampena M.B., D&#x2019;Andrea K., Manne S., Chen Z., Huang Y.J., Reilly J.P., Weisman A.R., Ittner C.A.G., Kuthuru O., Dougherty J., Nzingha Z., Han N., Kim J., Pattekar A., Goodwin E.C., Anderson E.M., Weirick M.E., Gouma S., Arevalo C.P., Bolton M.J., Chen F., Lacey S.F., Ramage H., Cherry S., Hensley S.E., Apostolidis S.A., Huang A.C., Vella L.A., Betts M.R., Meyer N.J., Wherry E.J. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369 doi: 10.1126/science.abc8511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009;33:355&#x2013;366. doi: 10.1016/j.neubiorev.2008.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2008.10.005</ArticleId><ArticleId IdType="pubmed">18996146</ArticleId></ArticleIdList></Reference><Reference><Citation>Meckiff B.J., Ram&#xed;rez-Su&#xe1;stegui C., Fajardo V., Chee S.J., Kusnadi A., Simon H., Eschweiler S., Grifoni A., Pelosi E., Weiskopf D., Sette A., Ay F., Seumois G., Ottensmeier C.H., Vijayanand P. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ TCells in COVID-19. Cell. 2020;183:1340&#x2013;1353.e16. doi: 10.1016/j.cell.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7534589</ArticleId><ArticleId IdType="pubmed">33096020</ArticleId></ArticleIdList></Reference><Reference><Citation>Milaneschi Y., Kappelmann N., Ye Z., Lamers F., Moser S., Jones P.B., Burgess S., Penninx B.W.J.H., Khandaker G.M. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol. Psych. 2021 In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8873022</ArticleId><ArticleId IdType="pubmed">34135474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli V., Pariante C.M. What can neuroimmunology teach us about the symptoms of long-COVID? Oxf. Open Immunol. 2021;2:1&#x2013;5. doi: 10.1093/oxfimm/iqab004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqab004</ArticleId><ArticleId IdType="pmc">PMC7928677</ArticleId><ArticleId IdType="pubmed">34192271</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriarity D.P., Horn S.R., Kautz M.M., Haslbeck J.M.B., Alloy L.B. How handling extreme C-reactive protein (CRP) values and regularization influences CRP and depression criteria associations in network analyses. Brain Behav. Immun. 2020 doi: 10.1016/j.bbi.2020.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.10.020</ArticleId><ArticleId IdType="pmc">PMC7753060</ArticleId><ArticleId IdType="pubmed">33342465</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaisen C., Figenschau Y., Nossent J.C. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J. Rheumatol. 2008;35:380&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">18260177</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M., Wang D.W., Han Y., Lewis D.B., Wu J.C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 2020;17:543&#x2013;558. doi: 10.1038/s41569-020-0413-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohleder N., Aringer M., Boentert M. Role of interleukin-6 in stress, sleep, and fatigue. Ann. N. Y. Acad. Sci. 2012;1261:88&#x2013;96. doi: 10.1111/j.1749-6632.2012.06634.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2012.06634.x</ArticleId><ArticleId IdType="pubmed">22823398</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi A., Tahmasebi S., Mahmood A., Kuznetsova M., Valizadeh H., Taghizadieh A., Nazemiyeh M., Aghebati&#x2010;Maleki L., Jadidi&#x2010;Niaragh F., Abbaspour&#x2010;Aghdam S., Roshangar L., Mikaeili H., Ahmadi M. Th17 and Treg cells function in SARS&#x2010;CoV2 patients compared with healthy controls. J. Cell. Physiol. 2021;236:2829&#x2013;2839. doi: 10.1002/jcp.30047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30047</ArticleId><ArticleId IdType="pubmed">32926425</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama C., Han J., Yau L., Reiss W.G., Kramer B., Neidhart J.D., Criner G.J., Kaplan-Lewis E., Baden R., Pandit L., Cameron M.L., Garcia-Diaz J., Ch&#xe1;vez V., Mekebeb-Reuter M., Lima de Menezes F., Shah R., Gonz&#xe1;lez-Lara M.F., Assman B., Freedman J., Mohan S.V. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N. Engl. J. Med. 2021;384:20&#x2013;30. doi: 10.1056/NEJMoa2030340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2030340</ArticleId><ArticleId IdType="pmc">PMC7781101</ArticleId><ArticleId IdType="pubmed">33332779</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller J., Garbers C., Rose-John S. Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities. Semin. Immunol. 2014;26:2&#x2013;12. doi: 10.1016/j.smim.2013.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2013.11.002</ArticleId><ArticleId IdType="pubmed">24325804</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze J.L., Aschenbrenner A.C. COVID-19 and the human innate immune system. Cell. 2021;184:1671&#x2013;1692. doi: 10.1016/j.cell.2021.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A., Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861&#x2013;880. doi: 10.1016/j.cell.2021.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T., Narazaki M., Kishimoto T. Therapeutic targeting of the interleukin-6 receptor. Annu. Rev. Pharmacol. Toxicol. 2012;52:199&#x2013;219. doi: 10.1146/annurev-pharmtox-010611-134715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010611-134715</ArticleId><ArticleId IdType="pubmed">21910626</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2020;0366:1&#x2013;11. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>The RECOVERY Collaborative Group Effect of hydroxychloroquine in hospitalized patients with Covid-19. N. Engl. J. Med. 2020;383:2030&#x2013;2040. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7556338</ArticleId><ArticleId IdType="pubmed">33031652</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., Lalla D., Woolley M., Jahreis A., Zitnik R., Cella D., Krishnan R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006;367:29&#x2013;35. doi: 10.1016/S0140-6736(05)67763-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)67763-X</ArticleId><ArticleId IdType="pubmed">16399150</ArticleId></ArticleIdList></Reference><Reference><Citation>Veiga V.C., Prats J.A.G.G., Farias D.L.C., Rosa R.G., Dourado L.K., Zampieri F.G., Machado F.R., Lopes R.D., Berwanger O., Azevedo L.C.P., Avezum &#xc1;., Lisboa T.C., Rojas S.S.O., Coelho J.C., Leite R.T., Carvalho J.C., Andrade L.E.C., Sandes A.F., Pint&#xe3;o M.C.T., Castro C.G., Santos S.V., de Almeida T.M.L., Costa A.N., Gebara O.C.E., de Freitas F.G.R., Pacheco E.S., Machado D.J.B., Martin J., Concei&#xe7;&#xe3;o F.G., Siqueira S.R.R., Damiani L.P., Ishihara L.M., Schneider D., de Souza D., Cavalcanti A.B., Scheinberg P. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021;372:84. doi: 10.1136/bmj.n84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n84</ArticleId><ArticleId IdType="pmc">PMC7815251</ArticleId><ArticleId IdType="pubmed">33472855</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>West A.P. Mitochondrial dysfunction as a trigger of innate immune responses and inflammation. Toxicology. 2017;391:54&#x2013;63. doi: 10.1016/j.tox.2017.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2017.07.016</ArticleId><ArticleId IdType="pubmed">28765055</ArticleId></ArticleIdList></Reference><Reference><Citation>White J., Kivim&#xe4;ki M., Jokela M., Batty G.D. Association of inflammation with specific symptoms of depression in a general population of older people: the English Longitudinal Study of Ageing. Brain Behav. Immun. 2017;61:27&#x2013;30. doi: 10.1016/j.bbi.2016.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.08.012</ArticleId><ArticleId IdType="pubmed">27562420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wium-Andersen M.K., &#xd8;rsted D.D., Nielsen S.F., Nordestgaard B.G. Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals. JAMA Psychiatry. 2013;70:176&#x2013;184. doi: 10.1001/2013.jamapsychiatry.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/2013.jamapsychiatry.102</ArticleId><ArticleId IdType="pubmed">23266538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Wang W., Li S., Yang H., Zhang M., Zhang P., Wen Y., Wu A., Yang L., Zhou B., Chen X. IL6 gene allele-specific C/EBP&#x3b1;-binding activity affects the development of HBV infection through modulation of Th17/Treg balance. Genes Immun. 2015;16:528&#x2013;535. doi: 10.1038/gene.2015.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2015.40</ArticleId><ArticleId IdType="pubmed">26447433</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Hao Y., Ou W., Ming F., Liang G., Qian Y., Cai Q., Dong S., Hu S., Wang W., Wei S. Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study. J. Transl. Med. 2020;18:1&#x2013;8. doi: 10.1186/s12967-020-02571-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02571-x</ArticleId><ArticleId IdType="pmc">PMC7594951</ArticleId><ArticleId IdType="pubmed">33121497</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>